source
- Natera partners with Angiex to evaluate Signatera blood test in AGX101 cancer trialNatera announced a collaboration with biotech Angiex to assess its Signatera circulating tumor DNA blood test in the context of Angiex’s early‑stage clinical trial of AGX101. Angiex, based in Camb…
- Industry insiders invited to take Q3 BioPharma Sentiment SurveySignal's Endpoints team is launching the third quarterly BioPharma Sentiment Index (BPSI) survey, a three minute questionnaire that captures industry views. The survey asks participants to share p…